Hemophagocytic Lymphohistiocytosis Terminated Phase 2 / 3 Trials for Cyclophosphamide (DB00531)

Back to Hemophagocytic Lymphohistiocytosis

Also known as: Hemophagocytic Lymphohistiocytosis (HLH) / Haemophagocytic Lymphohistiocytosis / Hemophagocytic Lymphohistiocytoses / Hemophagocytic Lymphohisticytosis / Hemophagocytic lymphohistiocytosis (disorder) / Lymphohistiocytosis, Hemophagocytic / Primary hemophagocytic lymphohistiocytosis / Primary haemophagocytic lymphohistiocytosis / Familial hemophagocytic lymphohistiocytosis (disorder) / Familial Hemophagocytic Lymphocytosis / Familial haemophagocytic lymphohistiocytosis / Familial hemophagocytic lymphohistiocytosis

Indication	Status	Phase
DBCOND0029166 (Hemophagocytic Lymphohistiocytosis)	Terminated	2 / 3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00176826	T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders	Treatment	Busulfan (DB01008) Cyclophosphamide (DB00531)